BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22787216)

  • 1. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.
    Schneider M; Ackermann K; Stuart M; Wex C; Protzer U; Schätzl HM; Gilch S
    J Virol; 2012 Sep; 86(18):10112-22. PubMed ID: 22787216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.
    Raaben M; Posthuma CC; Verheije MH; te Lintelo EG; Kikkert M; Drijfhout JW; Snijder EJ; Rottier PJ; de Haan CA
    J Virol; 2010 Aug; 84(15):7869-79. PubMed ID: 20484504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells.
    Lu CY; Huang HY; Yang TH; Chang LY; Lee CY; Huang LM
    Eur J Clin Microbiol Infect Dis; 2008 Aug; 27(8):709-15. PubMed ID: 18449585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome.
    Ma XZ; Bartczak A; Zhang J; Khattar R; Chen L; Liu MF; Edwards A; Levy G; McGilvray ID
    J Virol; 2010 Dec; 84(23):12419-28. PubMed ID: 20861244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.
    Adedeji AO; Singh K; Kassim A; Coleman CM; Elliott R; Weiss SR; Frieman MB; Sarafianos SG
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4894-8. PubMed ID: 24841268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected.
    Akerström S; Gunalan V; Keng CT; Tan YJ; Mirazimi A
    Virology; 2009 Dec; 395(1):1-9. PubMed ID: 19800091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.
    Wang Z; Ren L; Zhao X; Hung T; Meng A; Wang J; Chen YG
    J Virol; 2004 Jul; 78(14):7523-7. PubMed ID: 15220426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SARS-CoV replication by siRNA.
    Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
    Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Chan PK; Sidwell RW
    Antivir Chem Chemother; 2006; 17(5):275-84. PubMed ID: 17176632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Li N; Tian M; Jin N; Li X
    J Virol; 2021 Nov; 95(24):e0153721. PubMed ID: 34550769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.
    Akerström S; Mousavi-Jazi M; Klingström J; Leijon M; Lundkvist A; Mirazimi A
    J Virol; 2005 Feb; 79(3):1966-9. PubMed ID: 15650225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.
    Kawase M; Shirato K; van der Hoek L; Taguchi F; Matsuyama S
    J Virol; 2012 Jun; 86(12):6537-45. PubMed ID: 22496216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.
    Kumaki Y; Wandersee MK; Smith AJ; Zhou Y; Simmons G; Nelson NM; Bailey KW; Vest ZG; Li JK; Chan PK; Smee DF; Barnard DL
    Antiviral Res; 2011 Apr; 90(1):22-32. PubMed ID: 21338626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted.
    Inoue Y; Tanaka N; Tanaka Y; Inoue S; Morita K; Zhuang M; Hattori T; Sugamura K
    J Virol; 2007 Aug; 81(16):8722-9. PubMed ID: 17522231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
    Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
    J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
    Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
    Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry.
    Yu GY; Lai MM
    J Virol; 2005 Jan; 79(1):644-8. PubMed ID: 15596861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.